KVUE (Kenvue NYSE) +1.21% to $17.59 Feb 04 2026: earnings tomorrow
KVUE stock moved higher intraday to $17.59, up 1.21%, as investors position ahead of Kenvue Inc.’s earnings due on 05 Feb 2026. Trading volume hit 45,811,865 shares, above the 30-day average, showing active flows into the NYSE-listed consumer health name. This earnings spotlight will test revenue and margin momentum tied to brands like Tylenol and Neutrogena.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
